Skip to main content
Bliss GVS Pharma Limited logo

Bliss GVS Pharma Limited — Investor Relations & Filings

Ticker · BLISSGVS ISIN · INE416D01022 LEI · 335800GXY3YCGGP7KJ45 BSE.NS Manufacturing
Open in API
Filings indexed 1,245 across all filing types
Latest filing 2020-11-05 Regulatory Filings
Country IN India
Listing BSE.NS BLISSGVS

About Bliss GVS Pharma Limited

https://blissgvs.com/

Bliss GVS Pharma Limited specializes in the development, manufacturing, and marketing of diverse pharmaceutical formulations. The company is a global leader in the production of suppositories and pessaries, maintaining an extensive portfolio within these specialized dosage forms. Its therapeutic focus includes anti-malarials, anti-fungals, anti-bacterials, anti-inflammatories, and gastrointestinal treatments. The organization operates state-of-the-art manufacturing facilities compliant with international quality standards, including WHO-GMP. With a strategic focus on emerging markets, the company distributes its range of prescription and over-the-counter products across Sub-Saharan Africa, Southeast Asia, and Latin America, leveraging a robust supply chain to provide accessible healthcare solutions.

Recent filings

Filing Released Lang Actions
Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 please find enclosed disclosure of Related ....
Regulatory Filings
2020-11-05 English
Please find enclosed herewith the half yearly compliance certificate issued by Company Secretary in Practice as per Regulation 40(9) of the Securities and Exchange Board of India (Listing ....
Regulatory Filings
2020-10-29 English
In accordance with provisions of clause (c) of sub-regulation (8) of Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') we ....
Regulatory Filings
2020-10-23 English
Updates
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges (NSE and BSE) regarding the submission of an application for re-classification of promoters under Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It details changes in shareholding categories from 'Promoter & Promoter Group' to 'Public Category'. The content is regulatory in nature, notifying stock exchanges of shareholding reclassification, not a financial report, earnings release, or management discussion. The document length is 3742 characters, which is relatively short and primarily serves as an official notification. This fits the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2020-10-23 English
Pursuant to the provisions of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the extract copies of ....
Interim / Quarterly Report Classification · 95% confidence The document is a newspaper advertisement extract of unaudited financial results for the quarter and half year ended September 30, 2020. It includes financial data such as net profit, total income, and earnings per share for the quarter and half year, both standalone and consolidated. The document references Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates publication of financial results in newspapers. The document is not the full financial report but an extract or summary published as an advertisement. It contains substantive financial data and analysis for a period shorter than a full fiscal year (quarter and half year). Therefore, it fits the definition of an Interim / Quarterly Report (IR). The document length is 15,000 characters, indicating it is not a mere announcement or notice but contains detailed financial information. Hence, the classification is IR with high confidence.
2020-10-23 English
Copy of Newspaper Publication
Interim / Quarterly Report Classification · 95% confidence The document is titled as an extract of unaudited financial results for the quarter and half year ended September 30, 2020. It includes detailed financial data such as total income, profit/loss, equity share capital, and earnings per share for standalone and consolidated results. The document references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and mentions that the full detailed results are filed with stock exchanges. The document is about quarterly and half-year financial results with substantive financial data and analysis, not just an announcement or a certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2021
2020-10-23 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.